GSK plc Statistics

Total Valuation

GSK plc has a market cap or net worth of EUR 69.45 billion. The enterprise value is 85.29 billion.

Market Cap	69.45B
Enterprise Value	85.29B

Important Dates

The last earnings date was Wednesday, April 30, 2025.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	May 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.73%
Shares Change (QoQ)	-0.19%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.91B

Valuation Ratios

The trailing PE ratio is 18.43.

PE Ratio	18.43
Forward PE	n/a
PS Ratio	1.84
PB Ratio	4.26
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.17, with an EV/FCF ratio of 13.26.

EV / Earnings	22.63
EV / Sales	2.30
EV / EBITDA	8.17
EV / EBIT	11.58
EV / FCF	13.26

Financial Position

The company has a current ratio of 0.87, with a Debt / Equity ratio of 1.35.

Current Ratio	0.87
Quick Ratio	0.58
Debt / Equity	1.35
Debt / EBITDA	2.08
Debt / FCF	3.42
Interest Coverage	10.32

Financial Efficiency

Return on equity (ROE) is 27.10% and return on invested capital (ROIC) is 12.39%.

Return on Equity (ROE)	27.10%
Return on Assets (ROA)	6.55%
Return on Invested Capital (ROIC)	12.39%
Return on Capital Employed (ROCE)	15.68%
Revenue Per Employee	549,165
Profits Per Employee	54,918
Employee Count	68,629
Asset Turnover	0.53
Inventory Turnover	1.51

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.92% in the last 52 weeks. The beta is 0.30, so GSK plc's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	-13.92%
50-Day Moving Average	17.23
200-Day Moving Average	17.43
Relative Strength Index (RSI)	45.23
Average Volume (20 Days)	976,088

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GSK plc had revenue of EUR 37.69 billion and earned 3.77 billion in profits. Earnings per share was 0.91.

Revenue	37.69B
Gross Profit	27.10B
Operating Income	7.47B
Pretax Income	5.06B
Net Income	3.77B
EBITDA	10.34B
EBIT	7.47B
Earnings Per Share (EPS)	0.91

Full Income Statement

Balance Sheet

The company has 5.36 billion in cash and 22.03 billion in debt, giving a net cash position of -16.67 billion.

Cash & Cash Equivalents	5.36B
Total Debt	22.03B
Net Cash	-16.67B
Net Cash Per Share	n/a
Equity (Book Value)	16.32B
Book Value Per Share	4.14
Working Capital	-3.28B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.06 billion and capital expenditures -1.62 billion, giving a free cash flow of 6.43 billion.

Operating Cash Flow	8.06B
Capital Expenditures	-1.62B
Free Cash Flow	6.43B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 71.92%, with operating and profit margins of 19.83% and 10.00%.

Gross Margin	71.92%
Operating Margin	19.83%
Pretax Margin	13.42%
Profit Margin	10.00%
EBITDA Margin	27.45%
EBIT Margin	19.83%
FCF Margin	17.07%

Dividends & Yields

This stock pays an annual dividend of 0.72, which amounts to a dividend yield of 4.18%.

Dividend Per Share	0.72
Dividend Yield	4.18%
Dividend Growth (YoY)	7.59%
Years of Dividend Growth	1
Payout Ratio	78.91%
Buyback Yield	-0.73%
Shareholder Yield	3.45%
Earnings Yield	5.43%
FCF Yield	9.26%

Dividend Details

Stock Splits

The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.

Last Split Date	Jul 19, 2022
Split Type	Reverse
Split Ratio	0.8

Scores

GSK plc has an Altman Z-Score of 1.78. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.78
Piotroski F-Score	n/a